RCP
GILD icon

Rothschild Capital Partners’s Gilead Sciences GILD Stock Holding History

Rothschild Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,700
Closed -$153K – 73
2015
Q4 		$172K Buy
+1,700
New +$177K 0.09% 40
2015
Q1 		– Sell
-7,500
Closed -$707K – 44
2014
Q4 		$707K Buy
7,500
+5,000
+200% +$517K 0.34% 30
2014
Q3 		$266K Buy
+2,500
New +$245K 0.12% 36

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rothschild Capital Partners's GILD Position: Q1 2016 in Review

Rothschild Capital Partners sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 1,700 shares — an estimated $153K sold.

Rothschild Capital Partners first reported a position in GILD in Q3 2014 and held it in 3 quarters. The position peaked at $707K in Q4 2014. 1,629 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

  • Rothschild Capital Partners reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
  • Rothschild Capital Partners sold 1,700 Gilead Sciences shares in Q1 2016, an estimated $153K.
  • Rothschild Capital Partners first reported a position in Gilead Sciences in Q3 2014 and held it in 3 quarters.
  • Rothschild Capital Partners's Gilead Sciences position peaked at $707K in Q4 2014.
  • 1,629 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Rothschild Capital Partners's 13F filing for Q1 2016, filed 4 May 2016.